Amgen
AMGN
#105
Rank
$141.57 B
Marketcap
$263.38
Share price
0.84%
Change (1 day)
-4.29%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Revenue for Amgen (AMGN)

Revenue in 2024 (TTM): $32.53 Billion USD

According to Amgen's latest financial reports the company's current revenue (TTM ) is $32.53 Billion USD. In 2023 the company made a revenue of $28.19 Billion USD an increase over the revenue in the year 2022 that were of $26.32 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amgen from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $32.53 B15.41%
2023 $28.19 B7.09%
2022 $26.32 B1.32%
2021 $25.97 B2.18%
2020 $25.42 B8.83%
2019 $23.36 B-1.62%
2018 $23.74 B3.93%
2017 $22.84 B-0.62%
2016 $22.99 B6.14%
2015 $21.66 B7.97%
2014 $20.06 B7.43%
2013 $18.67 B8.17%
2012 $17.26 B10.8%
2011 $15.58 B3.51%
2010 $15.05 B2.81%
2009 $14.64 B-2.41%
2008 $15.00 B1.57%
2007 $14.77 B3.53%
2006 $14.26 B14.79%
2005 $12.43 B17.82%
2004 $10.55 B26.26%
2003 $8.35 B53.51%
2002 $5.44 B37.51%
2001 $3.95 B13.39%
2000 $3.49 B8.94%
1999 $3.20 B21.27%
1998 $2.64 B12.64%
1997 $2.34 B6.71%
1996 $2.19 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$60.11 B 84.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$47.43 B 45.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.25 B 23.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
$28.29 B-13.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.60 B-70.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$55.53 B 70.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$87.69 B 169.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.39 B-86.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.86 B 25.60%๐Ÿ‡บ๐Ÿ‡ธ USA